Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Can removing the catheter early speed up liver surgery recovery?

NCT ID NCT07733609

Symptom relief Sponsor: Yu Zhang Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jul 29, 2026 · Last updated Jul 30, 2026 · Updated 1 time

Summary

This trial investigates whether removing a urinary catheter within 6 hours after laparoscopic liver surgery, as part of an enhanced recovery program, improves urinary function and reduces complications. About 212 adults aged 18 to 75 with benign or malignant liver tumors scheduled for laparoscopic liver lobectomy will take part. The study compares early catheter removal to standard timing, measuring how long the catheter stays in and tracking recovery milestones.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
structured multidisciplinary Enhanced Recovery program with early catheter removal
What this could lead to
If early catheter removal proves safe and effective, it could become a standard part of recovery after laparoscopic liver surgery, reducing discomfort and speeding up hospital discharge.
What could go wrong
This is a single-center trial with 212 participants, so results may not apply to all hospitals or patients. Early removal might increase the risk of urinary retention or infection in some individuals.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

212 people

The number who actually took part.

Started

Sep 2025

Finished

Apr 2026

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 to 75 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: 1. Age 18 to 75 years. 2. Preoperative diagnosis of benign or malignant liver tumors, with a plan for standard laparoscopic liver lobectomy. 3. Liver function classified as Child-Pugh grade A. 4. Indocyanine green (ICG) 15-minute retention rate (ICG R15) \< 14%. 5. American Society of Anesthesiologists (ASA) physical status classification I-III. 6. Normal preoperative urinary function (residual urine volume \< 50 mL). 7. Provision of written informed consent. Exclusion Criteria: 1. Emergency surgery or conversion to an open surgical procedure. 2. Concurrent neurogenic bladder or chronic urinary tract infection. 3. Planned transfer to the intensive care unit (ICU) following surgery. 4. Anticipated intraoperative blood loss exceeding 1000 mL. 5. Presence of urethral stricture or complications related to intraoperative catheterization. 6. Unwillingness to participate in the trial.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Laparoscopic liver lobectomy are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

liver and intrahepatic bile duct neoplasm

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Laparoscopic liver lobectomy

Contacts and locations

Locations

  • the First Affiliated Hospital of Chongqing Medical University

    Chongqing, Chongqing Municipality, 400016, China

More trials for these conditions

Other studies related to the condition(s) this trial covers.